Overview
- Editors:
-
-
Patrick S. Parfrey
-
The Health Sciences Centre, Memorial University of Newfoundland, St. John’s, Canada
-
John D. Harnett
-
The Health Sciences Centre, Memorial University of Newfoundland, St. John’s, Canada
Access this book
Other ways to access
Table of contents (18 chapters)
-
-
Epidemiology
-
-
- Philip J. Held, Nathan W. Levin, Friedrich K. Port
Pages 3-17
-
- Robert N. Foley, Patrick S. Parfrey
Pages 19-38
-
- Patrick S. Parfrey, John D. Harnett
Pages 39-51
-
- Stephen G. Rostand, Edwin A. Rutsky
Pages 53-66
-
- Volker Wizemann, Wilfried Kramer
Pages 67-81
-
Pathogenesis
-
-
-
- Rainer Nowack, Alexander P. Mandelbaum, Eberhard Ritz
Pages 105-115
-
- Gerard M. London, Françoise Fabiani
Pages 117-137
-
- Shaul G. Massry, Miroslaw Smogorzewski, Alessandra F. Perna
Pages 139-160
-
- Allan D. Sniderman, Jonathan Silberberg, Sarah Prichard, Paul E. Barré
Pages 161-170
-
- Biff F. Palmer, William L. Henrich
Pages 171-185
-
-
- Leif Thuesen, Jens Sandahl Christiansen, Carl Erik Mogensen
Pages 205-217
-
Management
-
Front Matter
Pages 219-219
-
- John D. Harnett, Patrick S. Parfrey
Pages 221-229
-
- Edwin A. Rutsky, Stephen G. Rostand
Pages 231-246
-
- Louise F. Roy, Frans H. H. Leenen
Pages 247-266
About this book
Cardiac disease is the major cause of death in dialysis patients, accounting for over one third of deaths. This book focuses on myocardial function and dysfunction in chronic uremia. It is aimed at practicing and training nephrologists, cardiologists, and internists, and at research workers in the field. We have tried to produce an up-to-date, in-depth review of the subject by inviting experts in clinical epidemiology, pathophysiology, and thera peutics to write the 18 chapters. The book is divided into three sections. The first section comprises five chapters that provide an overview of the burden of illness associated with cardiac disease in end-stage renal disease and a review of clinical epidemi ological aspects of various cardiac diseases that occur in renal patients. The second section discusses abnormalities of left ventricular contractility and mass, and the factors that predispose to both systolic and diastolic disorders. The importance of hypertension, anemia, hyperparathyroidism, hyper lipidemia, and diabetes mellitus in predisposing to these abnormalities is reviewed splendidly by researchers active in these areas. The final section concentrates on therapeutics. Data and opinion on management of congestive heart failure, cardiomyopathy, coronary artery disease, hypertension, and arrhythmias are provided. In editing this book, we have reviewed an extensive literature, but un fortunately we have become more aware that substantial gaps in our knowl edge exist. Insufficient high-quality clinical research has been undertaken xiii xiv Preface regarding the various cardiac diseases that occur in end-stage renal disease.
Reviews
' .....and altogether it is a first-class review of the subject. ' Nephrology Dialysis Transplant 8:2: 1993
'I recommend this book to anyone who is involved in the management of ESRD patients or in the investigation of heart disease in the ESRD population.' Dialysis & Transplantation 22:2: 1993
'This book brings together a great deal of valuable information that should be of interest all nephrologists' The Lancet 340 1992
